Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
GENFIT
.
Show all posts
Showing posts with label
GENFIT
.
Show all posts
Wednesday, June 24, 2015
GFT505 demonstrates dose-dependent efficacy on primary endpoint in phase 2 NASH trial
›
GENFIT (Euronext: GNFT; ISIN: FR0004163111), today announces topline results of the phase 2 GOLDEN-505 trial in NASH. Due to...
›
Home
View web version
